Companies: 10,795·Total market cap: $144.5T
Aytu BioPharma, Inc.

Aytu BioPharma, Inc.

AYTUNASDAQHealthcare● Active
$2.29
+$0.04(+1.78%)
Market Cap$18547399
P/E Ratio
52W High$3.07
52W Low$1.46

Aytu BioPharma, Inc. (AYTU) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · AYTU · as of Sep 23, 2025

Latest filing snapshot

83
-19-18.63%vs prior year

Aytu BioPharma, Inc. (AYTU) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-06-30·Full-time · Global
Total Employees
83
Change (1Y)
-19
Growth % (1Y)
-18.63%
Revenue / Employee
$799.8K
Net Income / Employee
$-163.4K
Market Cap
$19M

AYTU Employee Count

2008 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2025-09-2383-19-18.63%
2024-09-26102-48-32.00%
2023-10-12150-14-8.54%
2022-09-27164-11-6.29%
2021-09-28175+100+133.33%
2020-10-0675+22+41.51%
2019-09-2653-4-7.02%
2018-09-0657-6-9.52%
2017-08-3163+5+8.62%
2016-09-0158+49+544.44%

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Drug Manufacturers - Specialty & Generic
#SymbolCompanyEmployees
#1
Adaptimmune Therapeutics plc
ADAP
Adaptimmune Therapeutics plc
506
#2
Allurion Technologies Inc.
ALUR
Allurion Technologies Inc.
134
#3
Adlai Nortye Ltd.
ANL
Adlai Nortye Ltd.
123
#4
Biofrontera Inc.
BFRI
Biofrontera Inc.
92
#5
Aytu BioPharma, Inc.
AYTU
Aytu BioPharma, Inc.YOU
83
#6
Ekso Bionics Holdings, Inc.
EKSO
Ekso Bionics Holdings, Inc.
61
#7
GeoVax Labs, Inc.
GOVX
GeoVax Labs, Inc.
17
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · AYTU peer comparison

About AYTU employees

AYTU Employees · Headcount

Aytu BioPharma, Inc. (AYTU) employee data is sourced from the annual SEC 10-K filing. As of 2025, Aytu BioPharma, Inc. had 83 full-time employees globally. Full-time employees only. Global consolidated headcount.

Aytu BioPharma, Inc. employs 83 full-time employees as of the latest filing within the Drug Manufacturers - Specialty & Generic industry. Revenue per employee stands at $799,783, reflecting the company's operational efficiency.

Aytu BioPharma, Inc.'s workforce decreased by 19 (18.63%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Aytu BioPharma, Inc.'s revenue per employee of $799,783 positions it among the notable performers in the Drug Manufacturers - Specialty & Generic sector for operational efficiency.

Frequently Asked Questions

AYTU Employees · 5 questions

As of the latest SEC 10-K filing (2025), Aytu BioPharma, Inc. had 83 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Aytu BioPharma, Inc. employee counthow many employees does Aytu BioPharma, Inc. haveAYTU total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-09-23